LENALIDOMIDE vs NINLARO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. LENALIDOMIDE and NINLARO are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	LENALIDOMIDE	NINLARO
Rating	70/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	LENALIDOMIDE	IXAZOMIB CITRATE
Manufacturer	Cipla	Takeda Pharms USA
Dosage forms	Capsule	Capsule
Drug class	Thalidomide Analog	—
Boxed warning	Boxed warning	None
Half-life	about 3 hours in healthy subjects, and 3 to 5 hours in patients with multiple myeloma, MDS, or mantle cell lymphoma	—
Treats	Multiple Myeloma, Myelodysplastic Syndromes, Mantle-Cell Lymphoma	Multiple Myeloma

lenalidomide ninlaro

Rating

70/100

New

Pharmacy pays

—

Type

Active ingredient

LENALIDOMIDE

IXAZOMIB CITRATE

Manufacturer

Cipla

Takeda Pharms USA

Dosage forms

Capsule

Drug class

Thalidomide Analog

—

Boxed warning

None

Half-life

about 3 hours in healthy subjects, and 3 to 5 hours in patients with multiple myeloma, MDS, or mantle cell lymphoma

—

Treats

Multiple Myeloma, Myelodysplastic Syndromes, Mantle-Cell Lymphoma

Multiple Myeloma

Frequently asked questions

What is the difference between Lenalidomide and Ninlaro?

Lenalidomide contains Lenalidomide, while Ninlaro contains Ixazomib Citrate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.